Suli Pharmaceutical-Providing CRO/CDMO services

Suli Group

Suli Pharmaceutical Technology Jiangyin Co., LTD., a wholly owned subsidiary of Suli Group, was established in 2009, consisting of Suli Pharma Shanghai R&D Center, Suli Pharma Jiangyin Production Site and Dalian Yongda-Suli Pharma. Relying on the company's technical advantages, suﬃcient production capability and capacity, lean management on production, safety and high standard GMP quality management...

Explore More ›

Our Vision :

Our Chemistry Makes the Synthesis Simpler

Our Mission :

Quality first and customer uppermost; high efficiency and sustainable development

Our Philosophy :

Good service, high efficiency, reliable credit

Suli Pharma Jiangyin

Dalian Yongda-Suli Pharma

Shanghai R&D center

Explore Suli Pharmaceutical

Products

· Intermediates
· Chiral Alcohols
· Chiral Amines
· Fluorochemicals
· Other Building Blocks
· Bulk Reagents

Facility

· R&D Center
· Kilo-Lab
· Facilities in Plant

Quality & HSE

· Quality
· Process & QC Facilities
· Health
· Safety
· Environment

Our Chemistry Makes the Synthesis Simpler！

Explore More ›

COOKIES

Our website uses cookies and similar technologies to personalize the advertising shown to you and to help you get the best experience on our website. For more information, see our Privacy & Cookie Policy

COOKIES

required

These cookies are necessary for basic functions such as payment. Standard cookies cannot be turned off and do not store any of your information.

analyze

These cookies collect information, such as how many people are using our site or which pages are popular, to help us improve the customer experience. Turning these cookies off will mean we can't collect information to improve your experience.

Feature

These cookies enable the website to provide enhanced functionality and personalization. They may be set by us or by third-party providers whose services we have added to our pages. If you do not allow these cookies, some or all of these services may not function properly.

advertise

These cookies help us understand what you are interested in so that we can show you relevant advertising on other websites. Turning these cookies off will mean we are unable to show you any personalized advertising.

NEWS

2024-07

Red and Yellow shares shrink, market value evaporates by $300 million What warning does it give to pharma?

2024-07

Pharmaceutical API industry must change the traditional marketing model

Add：No.2 Runhua Road, Harbour Economic Development District, Jiangyin, Jiangsu Province, China. 214444

Tel : +86-510-86631388

Website

yingjie.zhang@suli.com

+86-510-86631388